Market Closed -
London S.E.
11:35:12 2024-05-14 EDT
|
5-day change
|
1st Jan Change
|
100.5
GBX
|
+0.50%
|
|
+2.03%
|
+6.91%
|
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With a P/E ratio at 10.53 for the current year and 10 for next year, earnings multiples are highly attractive compared with competitors.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.95 for the current period. Therefore, the company is undervalued.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- Revenue estimates are regularly revised downwards for the current and coming years.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
|
1st Jan change
|
Capi.
|
Investor Rating
|
ESG Refinitiv
|
---|
| +6.91% | 116M | | C | | -9.18% | 749M | |
-
| | -2.20% | 635M | |
-
| | -20.08% | 607M |
-
|
-
| | -18.41% | 471M | |
-
| | +11.95% | 428M |
-
|
-
| | -19.21% | 275M |
-
|
-
| | -47.24% | 241M |
-
|
-
| | +17.97% | 213M | |
-
| | +6.15% | 207M |
-
|
-
|
4 months Revenue revision
Divergence of analysts' opinions
Divergence of Target Price
|